DCF — RIDGEVIEW MEDICAL CENTER
Enterprise Value: $-623.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-623.3M
Enterprise Value
$-194.0M
PV of Cash Flows
$-429.2M
PV of Terminal Value
$-691.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $296.5M | $-40.5M | -14.0% | $-53.1M | $-48.3M |
| Year 2 | $305.4M | $-38.7M | -13.0% | $-51.6M | $-42.7M |
| Year 3 | $314.5M | $-36.7M | -12.0% | $-50.0M | $-37.6M |
| Year 4 | $324.0M | $-36.2M | -11.0% | $-49.9M | $-34.1M |
| Year 5 | $333.7M | $-36.5M | -11.0% | $-50.6M | $-31.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-623.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$287.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14176518156002357
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5